83 related articles for article (PubMed ID: 31439134)
1. Response.
Repici A; Maselli R; Hassan C
Gastrointest Endosc; 2019 Sep; 90(3):533-534. PubMed ID: 31439134
[No Abstract] [Full Text] [Related]
2. Ideal submucosal injection solution for colorectal endoscopic submucosal dissection.
Matsushita M; Takahashi Y; Wakamatsu T; Nishio A; Seki T; Okazaki K
Gastrointest Endosc; 2019 Sep; 90(3):533. PubMed ID: 31439133
[No Abstract] [Full Text] [Related]
3. No risk reduction of colorectal adenoma with aspirin or eicosapentaenoic acid.
Dickson I
Nat Rev Gastroenterol Hepatol; 2019 Feb; 16(2):76. PubMed ID: 30626898
[No Abstract] [Full Text] [Related]
4. Eicosapentaenoic acid and aspirin for colorectal adenomas.
Danış N; Tekin F
Turk J Gastroenterol; 2019 Feb; 30(2):213-214. PubMed ID: 30843862
[No Abstract] [Full Text] [Related]
5. [Acetylsalicylic acid for prevention of colorectal adenomas. The APP Study].
Schmiegel W; Reinacher-Schick A
Internist (Berl); 2003 Oct; 44(10):1322-4. PubMed ID: 14689093
[No Abstract] [Full Text] [Related]
6. Interpreting the Benefit of Trifluridine/Tipiracil in Metastatic Colorectal Cancer With Respect to Progression-Free Survival and Overall Survival.
Sun R; Horiguchi M; Wei LJ
J Clin Oncol; 2018 May; 36(13):1378-1379. PubMed ID: 29558278
[No Abstract] [Full Text] [Related]
7. Take a pill for no more polyps: is it that simple?
Dekker E; Kaminski MF
Lancet; 2018 Dec; 392(10164):2519-2521. PubMed ID: 30466865
[No Abstract] [Full Text] [Related]
8. Dexmedetomidine for conscious sedation with colorectal endoscopic submucosal dissection: a prospective double-blind randomized controlled study.
Kinugasa H; Higashi R; Miyahara K; Moritou Y; Hirao K; Ogawa T; Kunihiro M; Nakagawa M
Clin Transl Gastroenterol; 2018 Jul; 9(7):167. PubMed ID: 29970896
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study.
Liu Z; Qin H; Yang Z; Xia Y; Liu W; Yang J; Jiang Y; Zhang H; Yang Z; Wang Y; Zheng Q
Aliment Pharmacol Ther; 2011 Jan; 33(1):50-63. PubMed ID: 21083585
[TBL] [Abstract][Full Text] [Related]
10. MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.
Hickish T; Andre T; Wyrwicz L; Saunders M; Sarosiek T; Kocsis J; Nemecek R; Rogowski W; Lesniewski-Kmak K; Petruzelka L; Apte RN; Mohanty P; Stecher M; Simard J; de Gramont A
Lancet Oncol; 2017 Feb; 18(2):192-201. PubMed ID: 28094194
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of synbiotic treatment before colorectal cancer surgery.
Krebs B; Horvat M; Golle A; Krznaric Z; Papeš D; Augustin G; Arslani N; Potrč S
Am Surg; 2013 Dec; 79(12):E340-2. PubMed ID: 24351338
[No Abstract] [Full Text] [Related]
12. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
13. Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
Sanoff HK; Goldberg RM; Ivanova A; O'Reilly S; Kasbari SS; Kim RD; McDermott R; Moore DT; Zamboni W; Grogan W; Cohn AL; Bekaii-Saab TS; Leonard G; Ryan T; Olowokure OO; Fernando NH; McCaffrey J; El-Rayes BF; Horgan AM; Sherrill GB; Yacoub GH; O'Neil BH
Cancer; 2018 Aug; 124(15):3118-3126. PubMed ID: 29905927
[TBL] [Abstract][Full Text] [Related]
14. A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.
Gillen DL; Meyskens FL; Morgan TR; Zell JA; Carroll R; Benya R; Chen WP; Mo A; Tucker C; Bhattacharya A; Huang Z; Arcilla M; Wong V; Chung J; Gonzalez R; Rodriguez LM; Szabo E; Rosenberg DW; Lipkin SM
Cancer Prev Res (Phila); 2015 Mar; 8(3):222-30. PubMed ID: 25604134
[TBL] [Abstract][Full Text] [Related]
15. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study.
Kapoor S; Pal S; Sahni P; Dattagupta S; Kanti Chattopadhyay T
J Surg Res; 2005 Dec; 129(2):172-5. PubMed ID: 15882879
[TBL] [Abstract][Full Text] [Related]
16. A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
Samonigg H; Wilders-Truschnig M; Kuss I; Plot R; Stöger H; Schmid M; Bauernhofer T; Tiran A; Pieber T; Havelec L; Loibner H
J Immunother; 1999 Nov; 22(6):481-8. PubMed ID: 10570746
[TBL] [Abstract][Full Text] [Related]
17. Double-blind randomised trial comparing 5-fluorouracil plus leucovorin to placebo for metastatic colorectal carcinoma.
Madden M; Goldberg P; Geddes C; Van der Merwe L
Colorectal Dis; 2005 Sep; 7(5):507-12. PubMed ID: 16108890
[TBL] [Abstract][Full Text] [Related]
18. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
[TBL] [Abstract][Full Text] [Related]
19. A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer.
Lim SH; Kim TW; Hong YS; Han SW; Lee KH; Kang HJ; Hwang IG; Lee JY; Kim HS; Kim ST; Lee J; Park JO; Park SH; Park YS; Lim HY; Jung SH; Kang WK
Br J Cancer; 2015 Nov; 113(10):1421-6. PubMed ID: 26505681
[TBL] [Abstract][Full Text] [Related]
20. Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer.
Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
Przegl Lek; 2000; 57 Suppl 5():142. PubMed ID: 11202281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
